TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24064252

Group type: COMPARATOR
Intervention: DeltatracII(®)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: QuarkRMR(®) using canopy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CCMexpress(®) using canopy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CCMexpress(®) using face tent
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: CCMexpress(®) using facemask
Number of subjects: 24
Study: 22092730

Group type: EXPERIMENTAL
Intervention: Low-intensity artificial daylight (0.5 mW/cm² - 3.7 mW/cm²)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional LED-PDT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-intensity artificial daylight
Number of subjects: 20
Study: 18045737

Group type: EXPERIMENTAL
Intervention: Cold saline solution (4 degrees C, 39.2 degrees F)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Room temperature saline solution (23 degrees C, 73.4 degrees F)
Number of subjects: 16
Study: 16428185

Group type: EXPERIMENTAL
Intervention: True interferences in subjects with a history of TMD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo interferences in subjects without a history of TMD
Number of subjects: 0
Study: 15332212

Group type: EXPERIMENTAL
Intervention: Furosemide (25 mg/kg/d intravenously or 35 mg/kg/d orally)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study: 11359591

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tramadol plus Bupivacaine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 63
Study: 9253964

Group type: EXPERIMENTAL
Intervention: Dorzolamide hydrochloride 2%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8491238

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg oral dose) during pregnancy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Postpartum (3-5 months after delivery)
Number of subjects: 8
Study: 3545842

Group type: EXPERIMENTAL
Intervention: Urokinase 2000 IU kg‐1 h‐1 for 24 hours + heparin
Number of subjects: 129

Group type: COMPARATOR
Intervention: Urokinase 4400 IU kg‐1 h‐1 for 12 hours + heparin
Number of subjects: 129
Study: 31489742

Group type: EXPERIMENTAL
Intervention: Combo stent (n = 124)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Taxus Liberté (n = 59)
Number of subjects: 183
Study: 29303790

Group type: EXPERIMENTAL
Intervention: 5-min standardized relaxation break before debriefing
Number of subjects: 149

Group type: COMPARATOR
Intervention: No relaxation break before debriefing (Control)
Number of subjects: 149
Study: 27236001

Group type: EXPERIMENTAL
Intervention: Adjuvant Systems AS01B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant Systems AS01E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant Systems AS03A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant Systems AS04
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alum
Number of subjects: 0
Study: 24916058

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Tapentadol ER (100-250 mg twice daily)
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Oxycodone HCl CR
Number of subjects: 1464
Study: 22398174

Group type: EXPERIMENTAL
Intervention: Simplified package (gravity and maternal effort)
Number of subjects: 24847

Group type: COMPARATOR
Intervention: Full package (controlled cord traction)
Number of subjects: 24847
Study: 20088723

Group type: EXPERIMENTAL
Intervention: Planned vaginal birth (VBAC)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Planned cesarean section (CS)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Women who changed from planned CS to VBAC
Number of subjects: 298
Study: 18030175

Group type: COMPARATOR
Intervention: estradiol valerate (2 mg daily)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: estradiol valerate in combination with testosterone undecanoate (40 mg every 2 days)
Number of subjects: 31
Study: 16161915

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/d)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/d)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 72
Study: 14522025

Group type: EXPERIMENTAL
Intervention: High-performance liquid chromatography (HPLC) method for cyclosporine determination
Number of subjects: 0
Study: 11157569

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in patients with MCD
Number of subjects: 20

Group type: COMPARATOR
Intervention: 1H‐MRSI in control subjects
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in perilesional tissue
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in contralateral tissue
Number of subjects: 20
Study: 9042703

Group type: EXPERIMENTAL
Intervention: Respirator wear condition
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control condition (without respirator)
Number of subjects: 9
Study: 7937232

Group type: EXPERIMENTAL
Intervention: Permanent bradycardia pacemakers
Number of subjects: 588

Group type: COMPARATOR
Intervention: Nonpacemaker patients
Number of subjects: 588
Study: 2895910

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 172

Group type: COMPARATOR
Intervention: Untreated eyes (Control)
Number of subjects: 172
Study: 31820841

Group type: EXPERIMENTAL
Intervention: Energy intake per actual body weight (BW) categorized into quartiles (Q)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Energy intake per standard or target BW
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for young-old population
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for old-old population
Number of subjects: 756
Study: 29214515

Group type: EXPERIMENTAL
Intervention: Training on a fundamentals of laparoscopic surgery (FLS™) standard box trainer
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Robotic computer based simulator (da Vinci Skills Simulator™)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No simulator training
Number of subjects: 27
Study: 27062954

Group type: EXPERIMENTAL
Intervention: Myofascial inhibitory technique (IT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Articulatory technique (AT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combined technique (IT and AT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80
Study: 25615001

Group type: EXPERIMENTAL
Intervention: Nurse-directed telephone intervention with up to 3 attempts to reach each patient.
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control group receiving standard pharmacy outreach (2 automated and 1 live call).
Number of subjects: 290
Study: 23870189

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg and propofol 1-2.5 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline 0.9% and propofol 1-2.5 mg/kg
Number of subjects: 60
Study: 20929120

Group type: EXPERIMENTAL
Intervention: Cuichan Zhunsheng Decoction (CZD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pitocin (control)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (simulator of CZD)
Number of subjects: 90
Study: 18979718

Group type: EXPERIMENTAL
Intervention: Fixed combination perindopril-indapamide
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11140
Study: 16802852

Group type: EXPERIMENTAL
Intervention: BIBN 4096 BS (single intravenous 10-minute infusion at different dose levels ranging from 0.25 to 10 mg)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: BIBN 4096 BS
Number of subjects: 126
Study: 12966321

Group type: EXPERIMENTAL
Intervention: Ethanol (0.3 g/kg for men, 0.2 g/kg for women)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 37
Study: 10983623

Group type: EXPERIMENTAL
Intervention: Breath-synchronized nebulization with mouthpiece
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Constant output nebulization with mouthpiece
Number of subjects: 158

Group type: COMPARATOR
Intervention: Nonsealing face mask with constant output nebulization
Number of subjects: 158
Study: 8638838

Group type: EXPERIMENTAL
Intervention: Stellate ganglion block with 7 ml 1% mepivacaine (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo with 7 ml saline (n = 5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular injection with 7 ml mepivacaine into the left deltoid muscle (n = 5)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 20
Study: 1282218

Group type: EXPERIMENTAL
Intervention: Synthetic substance P (SP) at doses of 0.5, 1, or 1.5 pmol/kg‐1/min‐1 over 60 min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Synthetic substance P (SP) at 1.5 pmol/kg‐1/min‐1 after pretreatment with sodium valproate (200 mg 16, 8 and 1 h before the SP test)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Synthetic substance P (SP) at the lowest dose (0.5 pmol/kg‐1/min‐1)
Number of subjects: 7
Study: 31326440

Group type: EXPERIMENTAL
Intervention: Regular package viewing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthier package viewing
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Tasting healthier product
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tasting regular product
Number of subjects: 34
Study: 28506776

Group type: EXPERIMENTAL
Intervention: Tai Chi or physical therapy exercise (12 weeks, twice per week)
Number of subjects: 86
Study: 25711628

Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart repair with ETAC (n = 44)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Arthroscopic Bankart repair without ETAC (n = 44)
Number of subjects: 88
Study: 24549145

Group type: EXPERIMENTAL
Intervention: CD4(+) T-cell ELISpot response at enrolment (n = 119)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Baseline CD4(+) cell ELISpot responses (n = 119)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: CD8(+) T-cell immunity
Number of subjects: 366
Study: 23936951

Group type: EXPERIMENTAL
Intervention: recombinant human erythropoietin (rHuEPO) and aggressive intravenous iron therapy
Number of subjects: 100
Study: 20825123

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bilateral treatment of equal intensity
Number of subjects: 12
Study: 18158722

Group type: EXPERIMENTAL
Intervention: 9.7 microm particles
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5.6 microm particles
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1.1 microm particles
Number of subjects: 19
Study: 16224652

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 40
Study: 11953921

Group type: EXPERIMENTAL
Intervention: Dietary energy intake (DEI)
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Dietary protein intake (DPI)
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Creatinine
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Normalized protein catabolic rate (nPCR)
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Equilibrated nPCR (enPCR)
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Functional status
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Comorbidities
Number of subjects: 1397
Study: 9646963

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8666002

Group type: COMPARATOR
Intervention: 447C88 200 mg single dose
Number of subjects: 26

Group type: COMPARATOR
Intervention: 447C88 800 mg single dose
Number of subjects: 26

Group type: COMPARATOR
Intervention: 447C88 200 mg twice daily for 10 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 2162255

Group type: EXPERIMENTAL
Intervention: KS1/4
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: KS1/4-methotrexate
Number of subjects: 11
Study: 374017

Group type: EXPERIMENTAL
Intervention: Sisomicin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 31995557

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200mg daily self-administered suppository)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 30784480

Group type: EXPERIMENTAL
Intervention: Combined stress (G2): nutritional stress (30% less of maintenance diet) and heat stress (38–44 °C for 6 h/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (G1): maintenance diet under shed
Number of subjects: 16
Study: 28794212

Group type: EXPERIMENTAL
Intervention: Fiber meatballs plus wheat bread
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-fiber meal (pork meatballs plus wheat bread)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fiber bread with pork meatballs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vegetable patties with natural fiber content plus wheat bread
Number of subjects: 40
Study: 26151178

Group type: EXPERIMENTAL
Intervention: Loading dose of 50,000 IU VTD3, followed by 25,000 IU at Week 4 and Week 8
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Loading dose of 100,000 IU VTD3, followed by 50,000 IU at Week 4 and Week 8
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Loading dose of 200,000 IU VTD3, followed by 100,000 IU at Week 4 and Week 8
Number of subjects: 150
Study: 23841960

Group type: EXPERIMENTAL
Intervention: MUFA-meal (high in oleic acid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: SFA-meal (high in palmitic acid)
Number of subjects: 20
Study: 21453832

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (TNT trial)
Number of subjects: 11840

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg (TNT trial)
Number of subjects: 11840

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day (IDEAL trial)
Number of subjects: 11840

Group type: COMPARATOR
Intervention: Simvastatin 20 mg/day (IDEAL trial)
Number of subjects: 11840

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day (SPARCL trial)
Number of subjects: 11840

Group type: COMPARATOR
Intervention: Placebo (SPARCL trial)
Number of subjects: 11840

Group type: EXPERIMENTAL
Intervention: Patients with new-onset T2DM (across trials)
Number of subjects: 11840

Group type: COMPARATOR
Intervention: Patients without new-onset T2DM (across trials)
Number of subjects: 11840
Study: 19306955

Group type: EXPERIMENTAL
Intervention: Preterm formula
Number of subjects: 202

Group type: COMPARATOR
Intervention: Banked breast milk
Number of subjects: 202

Group type: COMPARATOR
Intervention: Term formula
Number of subjects: 202
Study: 16705843

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Body acupuncture
Number of subjects: 90

Group type: COMPARATOR
Intervention: Western routine medical treatment (control)
Number of subjects: 90
Study: 11502699

Group type: EXPERIMENTAL
Intervention: Inherited bleeding tendency (hemophilia and von Willebrand disease)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Moderate to severe hemophilia
Number of subjects: 76
Study: 9266448

Group type: EXPERIMENTAL
Intervention: Intra-arterial carboplatin chemotherapy at a dose escalated to 1400 mg/hemisphere
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intra-arterial carboplatin chemotherapy
Number of subjects: 21
Study: 8303595

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 40
Study: 2979674

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg
Number of subjects: 6
Study: 29497759

Group type: EXPERIMENTAL
Intervention: Computer-based writing treatment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tau-U analysis
Number of subjects: 3
Study: 28460255

Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 38
Study: 26630568

Group type: EXPERIMENTAL
Intervention: Salacia reticulata extract
Number of subjects: 0
Study: 23520152

Group type: EXPERIMENTAL
Intervention: 10-week Internet-based cognitive-behavioral prevention program for AN
Number of subjects: 36
Study: 21496516

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) bibliotherapy, Japanese translation of a self-help book, duration: 2 months reading period followed by a 2-month follow-up.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Wait-list control group (received no intervention initially).
Number of subjects: 70
Study: 18299062

Group type: EXPERIMENTAL
Intervention: Wavefront-guided LASIK
Number of subjects: 27

Group type: COMPARATOR
Intervention: Wavefront-optimized LASIK
Number of subjects: 27
Study: 17196044

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)‐style acupuncture with manual stimulation for depression
Number of subjects: 151

Group type: COMPARATOR
Intervention: Nonspecific intervention using legitimate acupuncture points not specifically targeted to depressive symptoms
Number of subjects: 151

Group type: COMPARATOR
Intervention: Waitlist condition (no intervention for 8 weeks)
Number of subjects: 151
Study: 12499712

Group type: EXPERIMENTAL
Intervention: Mianserin 60 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 10693157

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg i.v.)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9322465

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 25 micrograms (Group S)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Extradural fentanyl 50 micrograms with bupivacaine (Group E)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Extradural bupivacaine only (Group C)
Number of subjects: 105
Study: 8478304

Group type: EXPERIMENTAL
Intervention: Dirithromycin 500 mg once daily
Number of subjects: 802

Group type: COMPARATOR
Intervention: Erythromycin 250 mg four times daily
Number of subjects: 802
Study: 3523664

Group type: EXPERIMENTAL
Intervention: Enprofylline (14.1 mg/kg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Theophylline (16.2 mg/kg/day)
Number of subjects: 15
Study: 31567764

Group type: EXPERIMENTAL
Intervention: Butorphanol 0.1 mg (group I)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Butorphanol 1 mg (group II)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline (group III)
Number of subjects: 120
Study: 28671104

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combined reversed temporal muscle flap and random forehead flap technique
Number of subjects: 43
Study: 25907982

Group type: EXPERIMENTAL
Intervention: Medial percutaneous hemi‐epiphysiodesis
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (no hemi‐epiphysiodesis)
Number of subjects: 9
Study: 24099352

Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 54
Study: 21948348

Group type: EXPERIMENTAL
Intervention: CAMS care
Number of subjects: 32

Group type: COMPARATOR
Intervention: Enhanced Care as Usual (E‐CAU)
Number of subjects: 32
Study: 19688316

Group type: EXPERIMENTAL
Intervention: Qiyu oil gauze (QYOG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vaseline gauze (Control)
Number of subjects: 60
Study: 18332644

Group type: EXPERIMENTAL
Intervention: SSRIs treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15550364

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Benzydamine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 34
Study: 11152373

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 24
Study: 9593078

Group type: EXPERIMENTAL
Intervention: Fluvastatin, 40 mg once daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pravastatin, 40 mg once daily
Number of subjects: 10
Study: 7640154

Group type: EXPERIMENTAL
Intervention: Intranasal administration of 1.0 mg clonazepam
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buccal administration of 1.0 mg clonazepam
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.5 mg clonazepam
Number of subjects: 7
Study: 2663163

Group type: EXPERIMENTAL
Intervention: guaimesal (500 mg, three times daily for seven days)
Number of subjects: 140

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study: 1096902

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 100
Study: 31370275

Group type: EXPERIMENTAL
Intervention: Two 45 min nutrition lessons using food models
Number of subjects: 203
Study: 28923239

Group type: EXPERIMENTAL
Intervention: PA101 (40 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 25316328

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Paracetamol with NAC administration
Number of subjects: 172
Study: 24090377

Group type: EXPERIMENTAL
Intervention: Phosphate binder (PB) adherence
Number of subjects: 502

Group type: COMPARATOR
Intervention: Cerebrovascular disease
Number of subjects: 502

Group type: COMPARATOR
Intervention: Higher PTH levels
Number of subjects: 502

Group type: COMPARATOR
Intervention: Lack of comprehension of appropriate PB use timing
Number of subjects: 502

Group type: COMPARATOR
Intervention: Stopping PB after feeling better
Number of subjects: 502

Group type: COMPARATOR
Intervention: Stopping PB after feeling worse
Number of subjects: 502

Group type: COMPARATOR
Intervention: Years on dialysis
Number of subjects: 502

Group type: COMPARATOR
Intervention: Serum phosphorus above 5.5 mg/dL
Number of subjects: 502

Group type: COMPARATOR
Intervention: Encouragement by dialysis staff to be independent
Number of subjects: 502

Group type: COMPARATOR
Intervention: Nephrologist explained PB use
Number of subjects: 502
Study: 21884146

Group type: EXPERIMENTAL
Intervention: Penthrox inhaler sedation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrous oxide sedation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both sedation techniques
Number of subjects: 20